Sarcoma, Alveolar Soft Part
Showing 51 - 75 of >10,000
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)
Not yet recruiting
- Advanced Soft-tissue Sarcoma
- LB-100 plus Doxorrubicin
- Doxorubicin
- (no location specified)
Apr 11, 2023
Neurosensory Disorder Trial in Cairo (inferior alveolar nerve lateralization and dental implant placement., platelet rich fibrin
Recruiting
- Neurosensory Disorder
- inferior alveolar nerve lateralization and dental implant placement.
- platelet rich fibrin membrane around the nerve
-
Cairo, EgyptFaculty of dentistry ,Cairo university
Mar 8, 2022
Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)
Recruiting
- Advanced Soft-tissue Sarcoma
- NY-ESO-1 TCR-T
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Alveolar Ridge Augmentation, Connective Tissue, Tooth Extraction Trial in Taipei (Alveolar ridge preservation)
Enrolling by invitation
- Alveolar Ridge Augmentation
- +3 more
- Alveolar ridge preservation
-
Taipei, TaiwanTri-Service General Hospital
May 26, 2023
Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle
Recruiting
- Sarcoma,Soft Tissue
- +2 more
- Fluzoparib
- Radioactive particle implantation
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 30, 2023
Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)
Completed
- Objective Response
- Overall Survival
- VIA combination treatment
-
Beijing, ChinaPeking University People's Hospital
Dec 9, 2022
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial
Not yet recruiting
- Hepatocellular Carcinoma
- BCLC Stage B Hepatocellular Carcinoma
- Atezolizumab Injection
- +2 more
- (no location specified)
Mar 16, 2023
Sarcoma Trial in Chapel Hill (GRID therapy)
Not yet recruiting
- Sarcoma
- GRID therapy
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill, Department of Radia
Oct 5, 2023
Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin
Completed
- Refractory or Recurrent Solid Tumors
- +3 more
- Eribulin mesilate
- Irinotecan hydrochloride
-
Marseille, Bouches-du-Rhône, France
- +38 more
Jun 20, 2022
Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)
Recruiting
- Soft Tissue Sarcoma
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 14, 2022
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)
Not yet recruiting
- Refractory Ewing Sarcoma
- +2 more
- (no location specified)
Feb 15, 2023
Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 10, 2021
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma
Recruiting
- Pediatric Soft Tissue Sarcoma
- detection and monitoring of cirulating tumor DNA
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 20, 2023
Soft Tissue Sarcoma Trial in New York (Tigilanol Tiglate)
Not yet recruiting
- Soft Tissue Sarcoma
- Tigilanol Tiglate
-
New York, New YorkMemorial Sloan Kettering Cancer Centre
Mar 2, 2023
Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,
Completed
- Metastatic Adult Soft Tissue Sarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Durvalumab and Tremelimumab
- Doxorubicin
-
Hannover, GermanyMedizinische Hochschule Hannover
Jan 18, 2023
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Sarcoma Trial in Arnhem, Nijmegen (Surgery)
Recruiting
- Sarcoma
- Surgery
-
Arnhem, Netherlands
- +1 more
May 16, 2022
Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma, Visceral Angiosarcoma Trial in Guam, United States (drug, biological,
Active, not recruiting
- Skin Angiosarcoma
- +2 more
- Cabozantinib S-malate
- +4 more
-
Phoenix, Arizona
- +171 more
Dec 28, 2022
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Tooth Extraction Status Nos Trial (Study Group, Control Group)
Not yet recruiting
- Tooth Extraction Status Nos
- Study Group
- Control Group
- (no location specified)
Nov 24, 2023
Sarcoma,Soft Tissue, Sarcoma Uterus Trial in United States (Niraparib)
Recruiting
- Sarcoma,Soft Tissue
- Sarcoma Uterus
-
Basking Ridge, New Jersey
- +6 more
Aug 23, 2022
Soft Tissue Sarcoma Trial in Washington (hypofractionation)
Not yet recruiting
- Soft Tissue Sarcoma
- hypofractionation
-
Washington, District of ColumbiaSibley Memorial Hospital
Jun 14, 2023